| Amedisys Hospice 5185 East River Road, Suite 201, Tucson, AZ, 85718 | |
| (520) 205-7700 |
News Archive
On the eve of the British Columbia inquiry into the death of Robert Dziekanski, a review of scientific data in CMAJ (Canadian Medical Association Journal) finds that in some cases, stun guns may stimulate the heart in experimental models. This evidence is contrary to current views that stun guns only affect skeletal muscles.
A type of prostate cell that has been largely ignored by cancer researchers can, in fact, trigger malignant prostate cancer, according to new studies by Howard Hughes Medical Institute (HHMI) scientists and their colleagues.
Three young investigators who have taken significant steps toward advancing the understanding of cancer will be the recipients of this year's Paul Marks Prize for Cancer Research, a prize awarded biennially since 2001 to scientists under the age of forty-six by Memorial Sloan-Kettering Cancer Center.
Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
› Verified 9 days ago
| Name | Amedisys Hospice |
|---|---|
| Location | 5185 East River Road, Suite 201, Tucson, Arizona |
| Hospice ID | 031501 |
| Category | Part of a hospital |
| Ownership Type | Voluntary Non-profit - Church |
| Profit Type | NON-PROFIT |
| SSA county code | 090 |
News Archive
On the eve of the British Columbia inquiry into the death of Robert Dziekanski, a review of scientific data in CMAJ (Canadian Medical Association Journal) finds that in some cases, stun guns may stimulate the heart in experimental models. This evidence is contrary to current views that stun guns only affect skeletal muscles.
A type of prostate cell that has been largely ignored by cancer researchers can, in fact, trigger malignant prostate cancer, according to new studies by Howard Hughes Medical Institute (HHMI) scientists and their colleagues.
Three young investigators who have taken significant steps toward advancing the understanding of cancer will be the recipients of this year's Paul Marks Prize for Cancer Research, a prize awarded biennially since 2001 to scientists under the age of forty-six by Memorial Sloan-Kettering Cancer Center.
Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
› Verified 9 days ago
| NPI Number | 1629444245 |
| Organization Name | Amedisys Hospice, Llc |
| Address | 1585 E River Rd Ste 201 Tucson, Arizona, 85718 |
| Phone Number | (520)205-7700 |
News Archive
On the eve of the British Columbia inquiry into the death of Robert Dziekanski, a review of scientific data in CMAJ (Canadian Medical Association Journal) finds that in some cases, stun guns may stimulate the heart in experimental models. This evidence is contrary to current views that stun guns only affect skeletal muscles.
A type of prostate cell that has been largely ignored by cancer researchers can, in fact, trigger malignant prostate cancer, according to new studies by Howard Hughes Medical Institute (HHMI) scientists and their colleagues.
Three young investigators who have taken significant steps toward advancing the understanding of cancer will be the recipients of this year's Paul Marks Prize for Cancer Research, a prize awarded biennially since 2001 to scientists under the age of forty-six by Memorial Sloan-Kettering Cancer Center.
Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
› Verified 9 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.9 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 83.8 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.7 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 76.4 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.9 | 97.3 |
| Patients who got timely treatment for shortness of breath | 95.8 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
On the eve of the British Columbia inquiry into the death of Robert Dziekanski, a review of scientific data in CMAJ (Canadian Medical Association Journal) finds that in some cases, stun guns may stimulate the heart in experimental models. This evidence is contrary to current views that stun guns only affect skeletal muscles.
A type of prostate cell that has been largely ignored by cancer researchers can, in fact, trigger malignant prostate cancer, according to new studies by Howard Hughes Medical Institute (HHMI) scientists and their colleagues.
Three young investigators who have taken significant steps toward advancing the understanding of cancer will be the recipients of this year's Paul Marks Prize for Cancer Research, a prize awarded biennially since 2001 to scientists under the age of forty-six by Memorial Sloan-Kettering Cancer Center.
Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
› Verified 9 days ago
| Home Health Aides | 3 |
| Counselors | 0.5 |
| Medical Social Workers | 1.5 |
| Physicians | 1.25 |
| Registered Nurses | 9 |
| Other Personnel | 7 |
| Total Employees | 22.25 |
|---|
News Archive
On the eve of the British Columbia inquiry into the death of Robert Dziekanski, a review of scientific data in CMAJ (Canadian Medical Association Journal) finds that in some cases, stun guns may stimulate the heart in experimental models. This evidence is contrary to current views that stun guns only affect skeletal muscles.
A type of prostate cell that has been largely ignored by cancer researchers can, in fact, trigger malignant prostate cancer, according to new studies by Howard Hughes Medical Institute (HHMI) scientists and their colleagues.
Three young investigators who have taken significant steps toward advancing the understanding of cancer will be the recipients of this year's Paul Marks Prize for Cancer Research, a prize awarded biennially since 2001 to scientists under the age of forty-six by Memorial Sloan-Kettering Cancer Center.
Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
› Verified 9 days ago
| Others | 18 |
| Total Volunteers | 18 |
|---|
News Archive
On the eve of the British Columbia inquiry into the death of Robert Dziekanski, a review of scientific data in CMAJ (Canadian Medical Association Journal) finds that in some cases, stun guns may stimulate the heart in experimental models. This evidence is contrary to current views that stun guns only affect skeletal muscles.
A type of prostate cell that has been largely ignored by cancer researchers can, in fact, trigger malignant prostate cancer, according to new studies by Howard Hughes Medical Institute (HHMI) scientists and their colleagues.
Three young investigators who have taken significant steps toward advancing the understanding of cancer will be the recipients of this year's Paul Marks Prize for Cancer Research, a prize awarded biennially since 2001 to scientists under the age of forty-six by Memorial Sloan-Kettering Cancer Center.
Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
› Verified 9 days ago
| Amedisys Hospice Location: 5185 East River Road, Suite 201, Tucson, Arizona, 85718 Phone: (520) 205-7700 |
| T M C Hospice Aka Peppi's House Location: 2715 North Wyatt Drive, Tucson, Arizona, 85712 Phone: (520) 205-7700 |
| Hospice Family Care, Inc. - Tucson Location: 6300 East El Dorado Plaza, A-100, Tucson, Arizona, 85715 Phone: (520) 205-7700 |
| Kindred Hospice Location: 5210 East Williams Circle, Suite 100, Tucson, Arizona, 85711 Phone: (520) 205-7700 |